Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis.

J Neuroinflammation · 2020 · PMC7296935 · PMID 32539719

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, patients in our cohort with stable disease showed a trend for reduced CD4+CD25+CD127+foxP3- Teff cells, most evident at M5, and Teff:Treg ratios that remained reduced from M5 to M48.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.